ESMO 2023 | Advancing sarcoma treatment: insights on combinations and trials

Robin L. Jones, MBBS, MRCP, MD, from the Institute of Cancer Research in London, UK, provides insights into combination therapies for sarcomas, highlighting the encouraging aspect of numerous ongoing prospective trials exploring novel combinations. Prof. Jones emphasizes the need to progress from exploratory, early-stage clinical trials to registration trials, aiming for increased drug approvals for patients with advanced sarcomas. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.